In vitro scintillation proximity assay measuring enzyme-dependent incorporation of 125 Figure 1 . High-throughput screen for Hhat inhibitors. a) Graphical description of the Hhat assay scheme used in the screen. C-terminally biotinylated Shh peptide (3.21µM) was incubated with 5µM 125 I-iodo-palmitoylCoA and membranes from Hhat transfected cells. The peptide was pulled down on streptavidin-coated SPA beads, and radiolabel incorporation was detected by scintillation counting. b) 63,885 unique structures were tested in the primary screen using the assay from a). 648 compounds were rescreened with the SPA-based assay and a cytotoxicity assay (see Online Methods). 95 compounds that displayed >60% inhibition in both assays were selected and IC50 values were determined. Based on the potency and chemical structure of the compounds, four hits, with the same core scaffold structure were selected. Figure 2 . IC50 curve for RU-SKI 43. 11-point 2-fold serial dilutions in DMSO were prepared to yield final concentrations of RU-SKI 43 ranging from 12.5µM to 0µM. The SPA-based Hhat activity assay, described in Online Methods, was performed in duplicate, and the data were used to calculate an IC50 value for RU-SKI 43. Each point represents the Mean±SD. 
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